Delivery Order SPE2DB22D2007-SPE2DB24FJ0YZ
Award Date 3/27/24
Potential Completion Date 4/17/24
Potential Value $4.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringes. The contract, valued at $13,857.59, has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical to supply a wide...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of STELARA 45 MG/0.5 ML VIAL 0.5ML pharmaceutical products. The contract, valued at $4,571.13, has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,571.13 to AmerisourceBergen Drug Corp for the supply of STELARA 45 MG/0.5 ML VIAL 0.5ML. This contract has an ultimate completion date of August 15, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $16,101.43 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The $14,179.06 firm-fixed price contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit subsidiary of AmerisourceBergen Corporation, to provide STELARA 45 mg/0.5 ml syringes. The $14,788.61 order has a completion date of February 13, 2024 and was awarded on February 12, 2024. This award is under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to deliver...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $9,537.86, is for the provision of 4564171786 STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184918 STELARA 90 MG/ML SYRINGEML. The $35,955.07 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a larger $999,999,999.00 indefinite delivery contract the company holds...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $3,343.24, is for the provision of 4564028021 STELARA 45 MG/0.5 ML SYRINGE 0.5ML. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,642.93 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564135022 STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The delivery order contract is part of a larger indefinite delivery contract valued up to $999,999,999.00, which...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0YZDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 45 MG/0.5 ML VIAL 0.5ML pharmaceuticals. The $4,571.13 contract has an ultimate completion date of April 17, 2024. AmerisourceBergen Drug Corp holds a $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical as the prime contractor, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.
Generated 6/26/24, 10:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 3/27/24 |